Stem cells and related research are all over the news, as amazing new applications for them are being studied, discovered and applied all the time.

This means you may have already heard of them. You may even know exactly what they are. But for anyone who wants a more in-depth knowledge of these potentially life-saving cells, read on.

This month, we celebrate achieving AABB accreditation – a globally renowned certification that recognises standards, practices and quality management in the collection, processing and storage of cord blood.

This is just the latest quality standard that we’ve attained. Most importantly we are licenced by the UK regulator the Human Tissue Authority (HTA) and have been since its formation. We are also authorised by the Financial Conduct Authority and approved by the National Association of Phlebotomists.

You may have heard about the Cells4Life ASA ruling on some claims we make in our marketing materials. Specifically, the claim that our TotiCyte processing method preserves 3 times more stem cells than our competitor’s systems.  This claim is based on extensive comparative testing of TotiCyte’s performance against the machines our competitors use.

The ASA have upheld a complaint by our competitors on a technicality. Simply, as we do not have access to our competitors’ exact laboratory procedures, the ASA contends that we cannot be completely assured that our data is representative of the results our competitors may achieve.